Why litigation finance needs sharper separation between legal progress, accounting value and recoverable cash.
The immediate debate in litigation finance is often about capital: who can raise it, recycle it, preserve it or deploy it. But the harder question is valuation.
Capital structure can solve a liquidity problem. It cannot, by itself, solve a confidence problem.
That distinction matters in legal assets, where reported value may depend less on observable market pricing than on internally assessed assumptions about probability, duration, enforcement and recovery.
Unlike most operating businesses, litigation finance platforms often report unrealised value movements on legal assets that remain subject to appeal, enforcement and collection risk. Fair value methodologies may therefore influence reported balance-sheet strength long before the underlying legal asset has been converted into recoverable cash.
This is not only an investor issue. Lawyers, claimants and insurers are also affected. If a legal claim cannot be valued with confidence, it becomes harder to fund, insure, monetise or settle. The quality of the legal case still matters, but capital increasingly asks a different question: how does the legal right convert into recoverable economics?
Outside litigation finance, legal claims are often treated more conservatively. Law firms generally do not recognise the future value of contingency matters as balance-sheet assets. Claimants may carry litigation costs, but not the expected value of unresolved claims. Insurers reserve against legal exposure rather than recognising anticipated litigation upside as unrealised value. Litigation finance is unusual because the legal asset itself may become part of reported investment value before recovery occurs.
The contrast becomes sharper in insolvency. A company may hold a valuable legal claim but remain balance-sheet insolvent because the expected litigation recovery is not recognised as an asset at anything close to its alleged economic value. Yet once that same claim is funded, acquired or economically participated in by a litigation funder, it may become part of an investment portfolio capable of fair value movement before recovery.
That raises an uncomfortable question: is the economic value in the legal asset, or in the accounting framework through which it is held?
Fair value accounting was not designed to make difficult assets simple. It was designed to make reported value more reflective of economic reality than historical cost. That has a clear logic in litigation finance.
A legal asset does not stand still. A claim at filing is not economically identical to a claim that has survived dismissal, produced a judgment, overcome appeal risk or moved into enforcement. To ignore that progression may understate genuine de-risking. Fair value allows investors to see that legal risk has changed before cash has been received.
That is the case for fair value. It is a serious one.
But legal assets also expose fair value’s limitations.
They are illiquid, idiosyncratic and path-dependent. Their value often turns on procedural moments that do not lend themselves easily to conventional financial modelling: a judicial finding, an appellate panel, a settlement window, a sovereign counterparty, or the practical enforceability of an award. Unlike listed securities, there is rarely a continuous market price against which assumptions can be tested.
That does not make fair value wrong. It makes it fragile.
The more an asset’s carrying value depends on judgment rather than observable pricing, the more investors need to understand what is actually being measured. A fair value mark is not cash, liquidity or necessarily monetisable value. It is an estimate of expected economic value under a set of legal, procedural and commercial assumptions.
The problem begins when that estimate starts to carry the psychological weight of realised performance.
There is also a deeper structural issue in litigation finance. The funder is often not merely underwriting an existing economic asset. The act of funding may be what allows the claim to become economically viable in the first place.
Without funding, a claimant may not be able to pursue the claim. A law firm may not be able to carry the duration. Experts may not be instructed. Adverse costs exposure may not be managed. Enforcement may never be reached.
In that sense, the funder’s due diligence does more than assess value. It may help create the conditions in which value can exist.
That creates a reflexive loop. The funder assesses the claim, prices the risk, provides the capital, supports the route to recovery and then participates in valuing the resulting asset. That is part of the function of litigation finance. But it also means external investors must distinguish between independent market pricing and internally interpreted legal-asset value.
In a single-asset transaction, that distinction may be manageable. Investors can interrogate the merits, budget, procedural posture, enforcement route, counterparty and economics. They can decide whether the price reflects the risk.
The difficulty increases materially in scaled platforms.
Once hundreds of matters are aggregated, external investors have limited ability to disaggregate case-level risk. Legal merits, procedural developments, settlement expectations, duration assumptions, enforcement risks and valuation movements are blended into portfolio-level reporting. Confidentiality, privilege and commercial sensitivity further restrict disclosure.
Investors are therefore often asked to assess the platform at a level of abstraction far removed from the underlying legal risk.
That creates a paradox.
An industry built around pricing, mitigating and managing legal risk may itself become difficult for external investors to independently risk-price when valuation is reported on a highly aggregated, internally modelled basis.
This is where valuation and portfolio construction meet.
Litigation finance returns are not produced like performing credit. They are lumpy, non-linear and often concentrated in a small number of outcomes. A portfolio may be diversified by case count, jurisdiction or capital deployed, yet still be economically concentrated if a small group of assets accounts for a disproportionate share of reported net asset value, unrealised gains or investor confidence.
If one asset, or a small number of assets, can materially alter market perception of a platform, then concentration exists in substance, whatever the formal exposure metrics may suggest.
This does not invalidate the asset class. It simply changes the questions investors should ask.
The next stage of institutionalisation may be less about whether litigation finance can generate attractive returns, and more about whether investors receive enough information to distinguish realised performance from valuation movement, case-level concentration from portfolio diversification, and legal progress from recoverable economics.
A judgment is not always a recovery. An award is not always cash. A strong legal position is not always an economic asset of equivalent quality.
Sophisticated investors will therefore focus less on whether a claim is legally strong in isolation and more on how value converts. Appeal exposure, duration, enforcement mechanics, settlement leverage, counterparty solvency, political risk and secondary market validation all become central to the pricing exercise.
That is the distinction between legal entitlement and economic recovery.
As litigation finance attracts broader pools of institutional capital, this distinction will matter more. Credit investors, insurers, family offices, hedge funds and asset managers will expect sharper reporting on concentration, realised cash performance, valuation movement and the relationship between reported NAV and monetised recovery.
Fair value has a legitimate role. Historical cost alone can obscure real economic progress. But fair value also requires discipline: conservative assumptions, clear disclosure, sensitivity analysis, evidence of secondary pricing where available, and a visible distinction between realised returns and unrealised movements.
Fair value may be necessary in litigation finance. But it should not be allowed to do more work than it can bear.
Until a legal entitlement has been tested by settlement, monetisation, enforcement or cash recovery, investors are not only underwriting litigation risk. They are underwriting the valuation architecture that sits around it.
At Wild Dog, we work at the intersection of litigation funding, ATE insurance, and structured capital, helping attorneys and their clients translate legal claims into investable, recoverable outcomes.
For those who want to follow how legal claims can be structured into fundable, recoverable outcomes, the Wild Dog newsletter link is below: